X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (3) 3
cancer (3) 3
female (3) 3
humans (3) 3
index medicus (3) 3
male (3) 3
middle aged (3) 3
cancer therapies (2) 2
hepatocellular carcinoma (2) 2
liver cancer (2) 2
multicenter (2) 2
product development (2) 2
survival (2) 2
tumors (2) 2
1st-line therapy (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv.mhep.heg]life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (1) 1
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (1) 1
abridged index medicus (1) 1
adult (1) 1
alanine transaminase - blood (1) 1
angiogenesis (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antiviral agents - therapeutic use (1) 1
article (1) 1
aspartate aminotransferases - blood (1) 1
bile duct neoplasms - drug therapy (1) 1
bile duct neoplasms - genetics (1) 1
bile ducts, intrahepatic (1) 1
brivanib (1) 1
carcinoma - drug therapy (1) 1
carcinoma - genetics (1) 1
carcinoma, hepatocellular - drug therapy (1) 1
carcinoma, hepatocellular - mortality (1) 1
carcinoma, hepatocellular - therapy (1) 1
care and treatment (1) 1
cetuximab (1) 1
chemotherapy (1) 1
cholangiocarcinoma - drug therapy (1) 1
cholangiocarcinoma - genetics (1) 1
choline (1) 1
cirrhosis (1) 1
cisplatin (1) 1
clinical trials (1) 1
clinical-trials (1) 1
coinfection - drug therapy (1) 1
coinfection - virology (1) 1
college teachers (1) 1
colorectal-cancer (1) 1
combination (1) 1
common bile duct neoplasms - drug therapy (1) 1
common bile duct neoplasms - genetics (1) 1
comparative analysis (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
diagnosis (1) 1
diagnostic radiology (1) 1
diagnostic systems (1) 1
digestive system diseases (1) 1
disease (1) 1
disease-free survival (1) 1
double-blind method (1) 1
drug dosages (1) 1
epidemiology (1) 1
failure (1) 1
family medical history (1) 1
fch (1) 1
features (1) 1
focal nodular hyperplasia (1) 1
france (1) 1
gall-bladder cancer (1) 1
gallbladder (1) 1
gallbladder neoplasms - drug therapy (1) 1
gallbladder neoplasms - genetics (1) 1
gastroenterology & hepatology (1) 1
gemcitabine (1) 1
growth-factor receptor (1) 1
hematology, oncology and palliative medicine (1) 1
hepatitis c - complications (1) 1
hepatitis c - drug therapy (1) 1
hepatoblastoma (1) 1
hepatoma (1) 1
hiv infections - complications (1) 1
hiv infections - drug therapy (1) 1
hiv/hcv co-infected patients (1) 1
hiv/hcv co‐infected patients (1) 1
human health and pathology (1) 1
human immunodeficiency virus--hiv (1) 1
human-immunodeficiency-virus (1) 1
hépatology and gastroenterology (1) 1
iii trial (1) 1
imaging / radiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 56 - 66
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 819 - 828
Summary Background Gemcitabine plus a platinum-based agent (eg, cisplatin or oxaliplatin) is the standard of care for advanced biliary cancers. We investigated... 
Hematology, Oncology and Palliative Medicine | GROWTH-FACTOR RECEPTOR | MULTICENTER | CISPLATIN | ONCOLOGY | COLORECTAL-CANCER | CLINICAL-TRIALS | GALLBLADDER | COMBINATION | TUMORS | CHEMOTHERAPY | GALL-BLADDER CANCER | ras Proteins - genetics | Peripheral Nervous System Diseases - chemically induced | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Alanine Transaminase - blood | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Oxaliplatin | Common Bile Duct Neoplasms - drug therapy | Adult | Bile Ducts, Intrahepatic | Female | Bile Duct Neoplasms - genetics | Cetuximab | Neutropenia - chemically induced | Common Bile Duct Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Carcinoma - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Gallbladder Neoplasms - drug therapy | Aspartate Aminotransferases - blood | Cholangiocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Cholangiocarcinoma - genetics | Carcinoma - genetics | Aged | Mutation | Deoxycytidine - analogs & derivatives | Chemotherapy | Product development | Gemcitabine | Comparative analysis | Cancer
Journal Article
by Gelu‐Simeon, Moana and Lewin, Maïté and Ostos, Maria and Bayan, Tatiana and Beso Delgado, Maria and Teicher, Elina and Layese, Richard and Roudot‐Thoraval, Françoise and Fontaine, Hélène and Sobesky, Rodolphe and Salmon‐Céron, Dominique and Samuel, Didier and Seror, Olivier and Nahon, Pierre and Meyer, Laurence and Duclos‐Vallée, Jean‐Charles and Petrov‐Sanchez, Ventzislava and Autran, Brigitte and Boufassa, Faroudy and Bourlière, Marc and Dominguez, Stéphanie and Hézode, Christophe and Pageaux, Georges‐Philippe and Poizot‐Martin, Isabelle and Roque‐Afonso, Anne‐Marie and Samri, Assia and Vittecoq, Daniel and Dabis, F and Winnock, M and Loko, A and Sogni, P and Benhamou, Y and Trimoulet, P and Izopet, J and Paradis, V and Spire, B and Carrieri, P and Katlama, C and Pialoux, G and Valantin, A and Bonnard, P and Poizot‐Martin, I and Marchou, B and Rosenthal, E and Garipuy, D and Bouchaud, O and Gervais, A and Lascoux‐Combe, C and Goujard, C and Lacombe, K and Duvivier, C and Vittecoq, D and Neau, D and Morlat, P and BaniSadr, F and Boufassa, F and Dominguez, S and Autran, B and Roque, M and Solas, C and Serfaty, L and Chêne, G and Costagliola, D and Zucman, D and Simon, A and Dominguez, S and Billaud, E and Miailhes, P and Devoto, J and Couffin‐Cadiergues, S and Nahon, P and Mahuas‐Bourcier, V and Zucman‐Rossi, J and Bedossa, P and Laurent, A and Layese, R and Durand‐Zaleski, I and Marche, P and Thibault, V and Guyader, D and Dharancy, S and Leroy, V and Vilgrain, V and Bonjour, M and Cagnot, C and Petrov‐Sanchez, V and ANRS CO13 HepaVih Study Grp and ANRS CO12 CirVir Study Grp and ANRS HC EP 25 Prethevic Study Grp and ANRS HC EP 25 Prethevic, ANRS CO13 HepaVih and ANRS CO12 CirVir Study Groups and the ANRS HC EP 25 Prethevic, ANRS CO13 HepaVih and ANRS CO12 CirVir Study Groups
Liver International, ISSN 1478-3223, 01/2019, Volume 39, Issue 1, pp. 136 - 146
Journal Article
Clinical and Translational Imaging, ISSN 2281-5872, 4/2014, Volume 2, Issue 2, pp. 103 - 113
Accurate detection of hepatocellular carcinoma (HCC) foci in the liver and at the whole-body level has a significant impact on patient management. Functional... 
Diagnostic Radiology | Hepatocellular carcinoma | FCH | Medical and Radiation Physics | Radiotherapy | Focal nodular hyperplasia | Medicine & Public Health | Choline | Nuclear Medicine | Interventional Radiology | Imaging / Radiology | Liver tumour | PET | Hepatoblastoma
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.